SI1734996T1 - Postopki in sestavki za zdravljenje in preprečevanje bolezni, povezane z integrinom alfa v beta 5 - Google Patents

Postopki in sestavki za zdravljenje in preprečevanje bolezni, povezane z integrinom alfa v beta 5

Info

Publication number
SI1734996T1
SI1734996T1 SI200531749T SI200531749T SI1734996T1 SI 1734996 T1 SI1734996 T1 SI 1734996T1 SI 200531749 T SI200531749 T SI 200531749T SI 200531749 T SI200531749 T SI 200531749T SI 1734996 T1 SI1734996 T1 SI 1734996T1
Authority
SI
Slovenia
Prior art keywords
integrin
beta
alpha
compositions
treating
Prior art date
Application number
SI200531749T
Other languages
English (en)
Inventor
Dean Sheppard
Amha Atakilit
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Priority claimed from EP05763460.2A external-priority patent/EP1734996B1/en
Publication of SI1734996T1 publication Critical patent/SI1734996T1/sl

Links

SI200531749T 2004-04-02 2005-03-30 Postopki in sestavki za zdravljenje in preprečevanje bolezni, povezane z integrinom alfa v beta 5 SI1734996T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55917504P 2004-04-02 2004-04-02
EP05763460.2A EP1734996B1 (en) 2004-04-02 2005-03-30 Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
PCT/US2005/011222 WO2005094391A2 (en) 2004-04-02 2005-03-30 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH αVβ5 INTEGRIN

Publications (1)

Publication Number Publication Date
SI1734996T1 true SI1734996T1 (sl) 2013-08-30

Family

ID=49078157

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531749T SI1734996T1 (sl) 2004-04-02 2005-03-30 Postopki in sestavki za zdravljenje in preprečevanje bolezni, povezane z integrinom alfa v beta 5

Country Status (2)

Country Link
ME (1) ME02086B (sl)
SI (1) SI1734996T1 (sl)

Also Published As

Publication number Publication date
ME02086B (me) 2014-02-28

Similar Documents

Publication Publication Date Title
HK1216080A1 (zh) 用於治療或預防草酸鹽相關疾病的組合物和方法
HRP20130782T1 (en) Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
EP1908779A4 (en) THYMOSINE BETA-4 DERIVATIVES AND USE THEREOF
HUE039034T2 (hu) Alfa v béta 6-ellenes antitestek és alkalmazásaik
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
TWI348891B (en) Composition for preventing plant diseases and method for preventing the diseases
EP1742640A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF ILLNESSES AND SUFFERING IN CONNECTION WITH THE MITOCHONDRY FUNCTION
EP1827389A4 (en) NANOTEHICOUS COMPOSITIONS WITH DELAYED RELEASE AND METHOD OF USE
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
EP1680009A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MENTAL ILLNESSES
EP1589996A4 (en) ANTI-INTEGRIN ALPHA BETA 3 ANTIBODY FORMULATIONS AND ITS USES
EP1978034A4 (en) ANTI-PERIOSTINE ANTIBODIES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PERIOSTIN-RELATED DISEASE CONTAINING THE ANTIBODY
ZA200707407B (en) Composition for preventing plant diseases and method for preventing the diseases
LT1921077T (lt) Agentas, skirtas miego sutrikimo gydymui ir (arba) prevencijai
EP1755537A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA
EP1512415A4 (en) LURE COMPOSITION FOR TREATING AND PREVENTING INFLAMMATORY DISEASES
AU2003212850A8 (en) Methods and compositions for treating cardiovascular disease
IL178598A0 (en) Skin-protecting alkalinity-controlling composition and the use thereof
EP1583966A4 (en) METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING GENES 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33
PL1762219T3 (pl) Fotoochronne i/lub fotoimmunoochronne kompozycje do skóry i ich zastosowania
EP1807067A4 (en) SPHINGOSINKINASE ACTIVATOR AND TREATMENT AGENT FOR SKIN DISEASES THEREWITH
HK1075272A1 (en) Dye composition and the use thereof
ME02086B (me) Postupci i smeše za lečenje i prevenciju bolesti koje su povezane sa alfa v beta 5 integrinom
EP1850827A4 (en) COMPOSITION FOR TREATING AND PREVENTING PERIODONTAL DISEASE AND USE METHOD